Program Guide – ASCO Meeting Program Guide
Eyob ale Tadesse Advocate Aurora Health, Milwaukee, WI Eyob ale Tadesse, Kayla Heslin, Mohamed Hendawi, Jonathan Hirsch, Christopher Idyro, Michael A. Thompson Advocate Aurora Health, Milwaukee, WI, Syapse, San Francisco, CA, Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI Background: Immune checkpoint inhibitor (ICI) therapy has become a mainstay of lung cancer treatment. However, not all NSCLC patients (pts) benefit, a subset paradoxically experience accelerated